Caplyta (lumateperone) and Vraylar (cariprazine) are brand-name oral capsules. They’re both prescribed for schizophrenia and depressive episodes of bipolar disorder. This article explains the main ...
New data from prospective real-world studies of VRAYLAR showed meaningful improvements in depressive symptoms, functioning and quality of life among adults living with major depressive disorder (MDD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results